World's Best Scientists 2026 revealed!
Hongliang Li

Hongliang Li

D-Index & Metrics

Medicine

D-Index
85
Citations
30218
World Ranking
14495
National Ranking
164

Hongliang Li publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hongliang Li sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 414 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hongliang Li D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hongliang Li sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hongliang Li is affiliated with Wuhan University in China. Their research spans multiple fields, with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader domains, key subfields of study include Molecular Biology, Epidemiology, Cardiology and Cardiovascular Medicine, Neurology, and Surgery.

The scientist's research addresses various topics, emphasizing Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, and Diet, Metabolism, and Disease. Other areas of work include Peroxisome Proliferator-Activated Receptors, Long-Term Effects of COVID-19, Endoplasmic Reticulum Stress and Disease, and Traumatic Brain Injury and Neurovascular Disturbances.

Frequent publication venues reflect the scientist's multidisciplinary reach and consist of:

  • Hepatology
  • Cell Metabolism
  • Frontiers in Endocrinology
  • Frontiers in Cardiovascular Medicine
  • Research Square (Research Square)

Notable recent papers authored or co-authored by Hongliang Li include:

  • Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes (2020, Cell Metabolism)
  • Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 (2020, Circulation Research)
  • Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease (2020, Free Radical Biology and Medicine)
  • The Science Underlying COVID-19 (2020, Circulation)
  • Epidemiological Features of NAFLD From 1999 to 2018 in China (2020, Hepatology)

Hongliang Li has collaborated frequently with several researchers, including:

  • Zhi-Gang She
  • Jingjing Cai
  • Xiao-Jing Zhang
  • Fang Lei
  • Peng Zhang

Best Publications

  • The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

    Guangwei Li;Ping Zhang;Jinping Wang;Edward W Gregg

  • Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.

    Lihua Zhu;Zhi Gang She;Xu Cheng;Juan Juan Qin

  • Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.

    Peng Zhang;Lihua Zhu;Jingjing Cai;Fang Lei

  • Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.

    Ze Chen;Ruifeng Tian;Zhigang She;Jingjing Cai

  • The Science Underlying COVID-19: Implications for the Cardiovascular System.

    Peter P. Liu;Alice Blet;Alice Blet;David Smyth;Hongliang Li

  • Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice

    Zhonglin Xie;Kai Lau;Bonnie Eby;Pedro Lozano

  • Epidemiological Features of NAFLD From 1999 to 2018 in China

    Jianghua Zhou;Feng Zhou;Wenxin Wang;Xiao-Jing Zhang

  • In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.

    Xiao Jing Zhang;Juan Juan Qin;Xu Cheng;Lijun Shen

  • Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.

    Feng Zhou;Jianghua Zhou;Wenxin Wang;Xiao-Jing Zhang

  • Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.

    Fang Lei;Ye Mao Liu;Feng Zhou;Juan Juan Qin

  • Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes.

    Chaoyong He;Huaiping Zhu;Hongliang Li;Ming Hui Zou

  • The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.

    Zhihua Wang;Xiao-Jing Zhang;Yan-Xiao Ji;Peng Zhang

  • Paraoxonase gene polymorphisms, oxidative stress, and diseases

    Hong-Liang Li;De-Pei Liu;Chih-Chuan Liang

  • Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

    Q. Gong;Q. Gong;E. W. Gregg;J. Wang;Y. An

  • Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol

    Khalidur Rahman;Khalidur Rahman;Chirayu Desai;Smita S. Iyer;Natalie E. Thorn

  • Autoimmune Basis for Postural Tachycardia Syndrome

    Hongliang Li;Xichun Yu;Campbell Liles;Muneer Khan

  • Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease

    Guang-Nian Zhao;Ding-Sheng Jiang;Hongliang Li

  • Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.

    Jiang-Hua Zhou;Jing-Jing Cai;Zhi-Gang She;Hong-Liang Li

  • Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

    Pi-Xiao Wang;Yan-Xiao Ji;Xiao-Jing Zhang;Ling-Ping Zhao

  • The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

    Yan-Xiao Ji;Peng Zhang;Xiao-Jing Zhang;Yi-Chao Zhao

Frequent Co-Authors

Jie Zeng
Jie Zeng University of Science and Technology of China
Xueyong Zhu
Xueyong Zhu Scripps Research Institute
De-Pei Liu
De-Pei Liu Peking Union Medical College Hospital
Madeleine W. Cunningham
Madeleine W. Cunningham University of Oklahoma Health Sciences Center
Yibin Wang
Yibin Wang University of California, Los Angeles
Christopher E. Aston
Christopher E. Aston University of Oklahoma Health Sciences Center
Qingbo Xu
Qingbo Xu King's College London
Benjamin J. Scherlag
Benjamin J. Scherlag University of Oklahoma Health Sciences Center
Michael Kramer
Michael Kramer Max Planck Institute for Radio Astronomy
Rui Si
Rui Si Brookhaven National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens several flexible pathways beyond a traditional MD. Many students consider nursing degrees, which can often be started online. For example, the online adn programs are known for their accessible admissions requirements and provide a solid foundation for future nursing roles.

If you already have an RN license and wish to advance, pursuing one of the cheapest rn to bsn online programs is a cost-effective option that also boosts career prospects.

Those holding a bachelor’s degree in another field but wanting to move into nursing can opt for online direct entry msn programs for non-nurses, offering a streamlined route to becoming a nurse practitioner or leader.

Alternatively, if you prefer working in allied health without direct patient care, medical billing and coding schools online provide training for vital healthcare administration roles, often with financial aid available.

Best Scientists Citing Hongliang Li

Trending Scientists

Recently Published Articles